Back to search

Article

Redefining hypo- and hyper-responding phenotypes of CFTR mutants for understanding and therapy

2022-09-13

Abstract excerpt

<h4>ABSTRACT</h4> Mutations in CFTR cause misfolding and decreased or absent ion-channel function, resulting in the disease Cystic Fibrosis. Fortunately, a triple-modulator combination therapy (Trikafta) has been FDA approved for 178 mutations, including all patients who have F508del on one allele. That so many CFTR mutants respond well to modulators developed for a single mutation is due to the nature of the fol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
92efea72-131b-5f7f-849d-4e051fcf5594
DOI
10.1101/2022.09.12.507537
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Redefining hypo- and hyper-responding phenotypes of CFTR mutants for understanding and therapyDOI 10.1101/2022.09.12.507537
Select a neighboring publication to make it the new centre.